Craft

Advanced
  • Home
  •  / Amphista Therapeutics
Amphista Therapeutics

Amphista Therapeutics

Total Funding

$60.5 M

Amphista Therapeutics Summary

Company Summary

Overview
Amphista Therapeutics is a biopharmaceutical company. It provides cancer therapeutics that harness the body's natural processes to degrade and remove disease-causing proteins.
Type
Private
Status
Active
Founded
2017
HQ
London, GB | view all locations
Website
https://www.amphista.com/
Cybersecurity rating
Sectors

Table of Contents

Key People

  • Nicola Thompson

    Nicola Thompson, CEO and Director

    • Ian Churcher

      Ian Churcher, CSO

      • Rogier Rooswinkel

        Rogier Rooswinkel, Non-Executive Director

        • Stefan Luzi

          Stefan Luzi, Non-Executive Director

          LocationsView all

          2 locations detected

          • London, England HQ

            United Kingdom

            158 N Gower St, Kings Cross

          • Motherwell, Scotland

            United Kingdom

            Bo'Ness Rd

          Competitors and Similar Companies

          Compare competitors

          Footer menu

          Product

          Solutions

          Resources

          Company

          © Craft.co 2026
          Share price data provided by IEX